首页 > 按专业查询名词 > 查询PubMed相关文献
名词信息
Pubmed相关的文献
hyperlipidemia, type Ⅲ 相关文献:
Epidemiology and management of hyperlipidemia.
Karr S.
Am J Manag Care. 2017 Jun;23(9 Suppl):S139-S148.
PMID:28978219
Lipid metabolism and hyperlipidemia in dogs.
Xenoulis PG, Steiner JM.
Vet J. 2010 Jan;183(1):12-21. doi: 10.1016/j.tvjl.2008.10.011. Epub 2009 Jan 23.
PMID:19167915
Postprandial Hyperlipidemia: Its Pathophysiology, Diagnosis, Atherogenesis, and Treatments.
Yanai H, Adachi H, Hakoshima M, Katsuyama H.
Int J Mol Sci. 2023 Sep 11;24(18):13942. doi: 10.3390/ijms241813942.
PMID:37762244
Hypertriglyceridaemia: an update.
Wierzbicki AS, Kim EJ, Esan O, Ramachandran R.
J Clin Pathol. 2022 Dec;75(12):798-806. doi: 10.1136/jclinpath-2021-207719. Epub 2022 Jun 16.
PMID:35710321
Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial.
Tong X, Xu J, Lian F, Yu X, Zhao Y, Xu L, Zhang M, Zhao X, Shen J, Wu S, Pang X, Tian J, Zhang C, Zhou Q, Wang L, Pang B, Chen F, Peng Z, Wang J, Zhen Z, Fang C, Li M, Chen L, Zhao L.
mBio. 2018 May 22;9(3):e02392-17. doi: 10.1128/mBio.02392-17.
PMID:29789365
Hyperlipidemia and Cardiovascular Disease in People with Type 1 Diabetes: Review of Current Guidelines and Evidence.
Karmali R, Sipko J, Majid M, Bruemmer D.
Curr Cardiol Rep. 2023 May;25(5):435-442. doi: 10.1007/s11886-023-01866-x. Epub 2023 Apr 13.
PMID:37052761
Lipoprotein glomerulopathy.
Tsimihodimos V, Elisaf M.
Curr Opin Lipidol. 2011 Aug;22(4):262-9. doi: 10.1097/MOL.0b013e328345ebb0.
PMID:21464714
Oleoylethanolamide alleviates hyperlipidaemia-mediated vascular calcification via attenuating mitochondrial DNA stress triggered autophagy-dependent ferroptosis by activating PPARalpha.
Chen Z, Sun X, Li X, Liu N.
Biochem Pharmacol. 2023 Feb;208:115379. doi: 10.1016/j.bcp.2022.115379. Epub 2022 Dec 13.
PMID:36525991
Type 3 resistant starch from Canna edulis reduce lipid levels in patients with mild hyperlipidemia through altering gut microbiome: A double- blind randomized controlled trial.
Miao T, Zhang X, Zhang C, Wu J, Zhu Y, Xiao M, Zhang N, Zhong Y, Liu Y, Lin Y, Wu Y, Li W, Song C, Liu Y, Wang X.
Pharmacol Res. 2024 Jul;205:107232. doi: 10.1016/j.phrs.2024.107232. Epub 2024 May 31.
PMID:38825157
Effect modification of hyperlipidemia and hypertension on the association between type 2 diabetes and gout.
Tung YC, Lee MY, Wang YC, Chang CJ, Tsai WC, Lin GT, Li CY, Lee SS, Tu HP.
Prim Care Diabetes. 2020 Dec;14(6):654-662. doi: 10.1016/j.pcd.2020.06.002. Epub 2020 Jun 24.
PMID:32593565
© Copyright 2021 鸿泰茂源  版权所有All Rights Reserved京ICP备11040441号-3